28 – 29 October 2021 | London, UK
+ Digital Day: 01 November 2021 | Online

Hans-Juergen Fuelle

Global Therapeutic Area Lead RA Pharmaceuticals GDD, NIBR DA Lead OPH & DAx for Early Development Regulatory Affairs
Hans-Juergen Fuelle
Hans-Juergen is a physician scientist with extensive experience in research and drug development in academia and the pharmaceutical industry. He is responsible for therapeutic areas such as ophthalmology, hepatology, nephrology, and hematology at the Novartis Institutes for BioMedical Research (NIBR), providing regulatory leadership for rare diseases programs, regenerative medicines, and advanced therapy medicinal products. Previously he held strategic roles in regulatory affairs across all stages of global development of medicinal products from early to confirmatory clinical development, registration, and post-marketing in the U.S., EU, and other major regions.


No data was found